[Adverse cognitive effects and ECT]
- PMID: 16823537
- DOI: 10.1007/s10354-005-0237-6
[Adverse cognitive effects and ECT]
Abstract
Electroconvulsive therapy (ECT) is a rapidly acting and highly effective treatment for severe and life threatening conditions seen in affective and schizophrenic diseases. Notwithstanding its therapeutic benefits, ECT remains controversial because of seizure induction, cognitive side effects, memory dysfunction and effects on cerebral physiology. These factors have raised the concern that ECT produces structural and functional brain damages. This issue continues to have a major impact on the acceptance of ECT as a therapeutic modality, both within the medical community and in public opinion. A close look at incidence, type, severity, neurofunctional and -anatomical correlates, aetiology and therapeutic approaches of the adverse cognitive effects attributed to ECT may contribute to rational and objective handling of this topic. The final chapter deals with the issue of whether ECT causes brain damage.
Similar articles
-
Shock treatment, brain damage, and memory loss: a neurological perspective.Am J Psychiatry. 1977 Sep;134(9):1010-4. doi: 10.1176/ajp.134.9.1010. Am J Psychiatry. 1977. PMID: 900284
-
Neurobiological correlates of the cognitive side effects of electroconvulsive therapy.J ECT. 2008 Mar;24(1):40-5. doi: 10.1097/YCT.0b013e31815d6957. J ECT. 2008. PMID: 18379334 Review.
-
Interictal slow-wave focus in left medial temporal lobe during bilateral electroconvulsive therapy.Neuropsychobiology. 2005;52(4):183-9. doi: 10.1159/000088861. Epub 2005 Oct 10. Neuropsychobiology. 2005. PMID: 16220024 Clinical Trial.
-
Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy.Brain Stimul. 2008 Jan;1(1):16-26. doi: 10.1016/j.brs.2007.08.005. Epub 2007 Dec 3. Brain Stimul. 2008. PMID: 20633366
-
Continuation and maintenance ECT: a review of recent research.J ECT. 2002 Sep;18(3):149-58. doi: 10.1097/00124509-200209000-00007. J ECT. 2002. PMID: 12394534 Review.
Cited by
-
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.Front Psychiatry. 2024 Feb 15;15:1359088. doi: 10.3389/fpsyt.2024.1359088. eCollection 2024. Front Psychiatry. 2024. PMID: 38426002 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical